EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allostatic load and progression of cardio-renal multimorbidity: A UK biobank study

Qianshen Zhu, Lingling Xu, Zhixing Fan, Hongbo Li iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0339576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Qianshen Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Tech…. Hauptthemen laut MEDLINE: Allostasis, Renal Insufficiency, Chronic, Cardiovascular Diseases, Multimorbidity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardio-renal multimorbidity (CRM), the coexistence of cardiovascular disease (CVD) and chronic kidney disease (CKD), imposes a significant healthcare burden. Allostatic load (AL), indicating cumulative physiological dysregulation from chronic stress, may be a modifiable risk factor for CRM.

Methods

This study included 396,927 participants with a median follow-up of 13.67 years. AL was assessed via 10 biomarkers. Multistate models were used to analyze transitions from health to first cardio-renal disease (FCRD), to CRM, and to death.

Results

Higher AL was significantly associated with increased risks of progression from health to FCRD, to CRM, and to death. The transition from FCRD to CRM was most affected by high AL. AL also had a stronger association with the transition from health to CKD than to CVD. Stratified analyses showed more pronounced associations in younger participants, those with higher socioeconomic status (SES), and unhealthy diets.

Conclusion

AL is a significant upstream factor in CRM development and progression. Early identification of individuals with high AL could aid in risk assessment and prevention strategies for CRM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllostasisRenal Insufficiency, ChronicCardiovascular DiseasesMultimorbidityHumansMaleFemaleMiddle AgedDisease ProgressionAgedUnited KingdomBiological Specimen BanksRisk FactorsAdultBiomarkersUK Biobank

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Hematology and Rheumatology, Wuhan Sixth Hospital Affiliated to Jianghan University, Wuhan, China.
  • Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, Yichang, China.

ORCID-Profile: Hongbo Li

Zitieren

APA

Zhu, Q., Xu, L., Fan, Z., & Li, H. (2026). Allostatic load and progression of cardio-renal multimorbidity: A UK biobank study. PLOS One. https://doi.org/10.1371/journal.pone.0339576

Vancouver

Zhu Q, Xu L, Fan Z, Li H. Allostatic load and progression of cardio-renal multimorbidity: A UK biobank study. PLOS One. 2026. doi:10.1371/journal.pone.0339576

BibTeX
@article{Zhu2026,
  author = {Zhu, Qianshen and Xu, Lingling and Fan, Zhixing and Li, Hongbo},
  title = {Allostatic load and progression of cardio-renal multimorbidity: A UK biobank study},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0339576}
}
Kostenlos starten →